Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Apr;47(4):549-556.
doi: 10.1007/s00449-024-02986-6. Epub 2024 Mar 18.

Development strategy of non-GMO organism for increased hemoproteins in Corynebacterium glutamicum: a growth-acceleration-targeted evolution

Affiliations

Development strategy of non-GMO organism for increased hemoproteins in Corynebacterium glutamicum: a growth-acceleration-targeted evolution

Sehyeon Park et al. Bioprocess Biosyst Eng. 2024 Apr.

Abstract

Heme, found in hemoproteins, is a valuable source of iron, an essential mineral. The need for an alternative hemoprotein source has emerged due to the inherent risks of large-scale livestock farming and animal proteins. Corynebacterium glutamicum, regarded for Qualified Presumption of Safety or Generally Recognized as Safe, can biosynthesize hemoproteins. C. glutamicum single-cell protein (SCP) can be a valuable alternative hemoprotein for supplying heme iron without adversely affecting blood fat levels. We constructed the chemostat culture system to increase hemoprotein content in C. glutamicum SCP. Through adaptive evolution, hemoprotein levels could be naturally increased to address oxidative stress resulting from enhanced growth rate. In addition, we used several specific plasmids containing growth-accelerating genes and the hemA promoter to expedite the evolutionary process. Following chemostat culture for 15 days, the plasmid in selected descendants was cured. The evolved strains showed improved specific growth rates from 0.59 h-1 to 0.62 h-1, 20% enhanced resistance to oxidative stress, and increased heme concentration from 12.95 µg/g-DCW to 14.22-15.24 µg/g-DCW. Notably, the putative peptidyl-tRNA hydrolase-based evolved strain manifested the most significant increase (30%) of hemoproteins. This is the first report presenting the potential of a growth-acceleration-targeted evolution (GATE) strategy for developing non-GMO industrial strains with increased bio-product productivity.

Keywords: Corynebacterium glutamicum; Adaptive evolution; Hemoproteins; Positive feedback.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest. The funders had no role in the design of the study and the interpretation of data.

Figures

Fig. 1
Fig. 1
a Growth curves and heme concentrations of C. glutamicum. b Heme concentration of C. glutamicum depends on the specific growth rate (µ). Open circles indicate log (OD600), and closed circles indicate heme concentration
Fig. 2
Fig. 2
Schematic diagram of GATE. The red neon sign means activation of PhemA. The gray arrow indicates the one direction of normal evolution. The blue arrow is a positive feedback loop formed by the specific plasmid is present
Fig. 3
Fig. 3
Schematic diagram of chemostat culture and evolution selection. The chemostat culture was conducted for 15 days. The PhemA-SBP-containing strain was eliminated. After plasmid curing, EvolCspA, EvolPth, and EvolRamA were selected
Fig. 4
Fig. 4
Assessment of oxidative stress resistance and specific growth rate (µ) at the mid-log phase (4–5 h of culture). Resistance to oxidative stress was displayed as intracellular ROS levels. White bars indicate relative ROS levels, and closed circles indicate µ
Fig. 5
Fig. 5
Measurement of intracellular heme amount and concentration at the mid-log phase (4–5 h of culture). White bars indicate heme amount, and closed circles indicate heme concentration

Similar articles

References

    1. Killip S, Bennett JM, Chambers MD. Iron deficiency anemia. Am Fam Physician. 2007;75(5):671–678. - PubMed
    1. Iqbal S, Ekmekcioglu C. Maternal and neonatal outcomes related to iron supplementation or iron status: a summary of meta-analyses. J Matern Fetal Neonatal Med. 2019;32:1528–1540. doi: 10.1080/14767058.2017.1406915. - DOI - PubMed
    1. Lopez A, Cacoub P, Macdougall IC, Peyrin-Biroulet L. Iron deficiency anaemia. Lancet. 2016;387:907–916. doi: 10.1016/S0140-6736(15)60865-0. - DOI - PubMed
    1. Cairo G, Bernuzzi F, Recalcati S. A precious metal: iron, an essential nutrient for all cells. Genes Nutr. 2006;1:25–39. doi: 10.1007/BF02829934. - DOI - PMC - PubMed
    1. Hurrell R, Egli I. Iron bioavailability and dietary reference values. Am J Clin. 2010;91:1461S–1467S. doi: 10.3945/ajcn.2010.28674F. - DOI - PubMed

LinkOut - more resources